Common gastrointestinal AEs include: Nausea: The most frequently reported adverse event, with an incidence of 44% in the semaglutide group compared to 18% in the placebo group during the STEP-1 trial
It decreases glucagon production, which prevents your liver from dumping stored glucose into your bloodstream
Dual-acting peptide with prolonged glucagon-like peptide-1 receptor agonist and glucagon receptor antagonist activity for the treatment of type 2 diabetes
Garvey WT, Frias JP, Jastreboff AM et al (2023) Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Furthermore, a doctor knows what signs to look for to show that you have vitamin B12 deficiency, so that you only get the dose you need
The bottom line A combination of two hormones (GLP-1 and GIP), Mounjaro can be effective for managing blood sugar levels in people with type 2 diabetes